Information Letter on Procoralan®: Potentially dangerous bradycardia
2014.06.11
Active substance: ivabradine
The company Servier Deutschland GmbH has issued a reminder that specific conditions for use must be observed in order to avoid potentially dangerous bradycardia when administering the medicinal product Procoralan® containing ivabradine for symptomatic treatment of chronic stable angina pectoris.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN